Baker Brothers Life Sciences LP, Director, 10% Owner at GENOMIC HEALTH INC (GHDX), sold 256,035 shares at $79.07 ($20.2M) on 2018-11-30, disclosed to the SEC on 2018-12-03.
Open-market sale of $20.2M GHDX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $77.61 | 30,257 | $2.3M | 11.6% |
| 2 | $77.61 | 35 | $3K | 0.0% |
| 3 | $77.61 | 465 | $36K | 0.2% |
| 4 | $77.61 | 518 | $40K | 0.2% |
| 5 | $77.61 | 801 | $62K | 0.3% |
| 6 | $77.61 | 4,646 |
| $361K |
| 1.8% |
| 7 | $78.80 | 14 | $1K | 0.0% |
| 8 | $78.80 | 11,994 | $945K | 4.7% |
| 9 | $78.80 | 184 | $14K | 0.1% |
| 10 | $78.80 | 206 | $16K | 0.1% |
| 11 | $78.80 | 317 | $25K | 0.1% |
| 12 | $78.80 | 1,841 | $145K | 0.7% |
| 13 | $79.07 | 129,121 | $10.2M | 50.5% |
| 14 | $79.07 | 151 | $12K | 0.1% |
| 15 | $79.07 | 1,981 | $157K | 0.8% |
| 16 | $79.07 | 2,214 | $175K | 0.9% |
| 17 | $79.07 | 3,417 | $270K | 1.3% |
| 18 | $79.07 | 19,824 | $1.6M | 7.8% |
| 19 | $79.63 | 46 | $4K | 0.0% |
| 20 | $79.63 | 39,591 | $3.2M | 15.6% |
| 21 | $79.63 | 608 | $48K | 0.2% |
| 22 | $79.63 | 678 | $54K | 0.3% |
| 23 | $79.63 | 1,048 | $83K | 0.4% |
| 24 | $79.63 | 6,078 | $484K | 2.4% |
| Total | $78.95 avg | 256,035 | $20.2M | 100% |
| Filing → |
| IGMS | BUY | 2023-12-15 | $5.4M | — | Filing → |
| MDGL | BUY | 2023-11-21 | $22.1M | — | Filing → |
| BGNE | SELL | 2023-11-14 | $198.6M | — | Filing → |